Douoguih, MacAya，现任职于Johnson & Johnson，曾任职于United States Department of Health and Human Services机构，个人H指数为20，累计发表论文67篇，论文总被引数累计3291次，主要研究方向涵盖医学、免疫学与微生物学、药理学,毒理学和药剂学、兽医学等领域，在New …

Jul 21, 2020 · Macaya Douoguih is the Head of Clinical Development and Medical Affairs in Janssen Vaccines, and a member of the Vaccines Senior Leadership Team. Macaya heads a team of

Sep 29, 2022 · As a U.S. scientist whose family has roots in Côte d’Ivoire (Ivory Coast) in Africa, Dr. Douoguih is one of the world’s foremost women of color in the life sciences. Her rise to leadership has been rapid. Currently, Macaya is Head of Clinical Development and Medical Affairs for Vaccines at Johnson & Johnson. In that post she directs major ...

Macaya DOUOGUIH | Cited by 4,859 | | Read 70 publications | Contact Macaya DOUOGUIH

View FREE Public Profile & Reputation for Macaya Douoguih in Reston, VA - Court Records | Photos | Address, Emails & Phone | Reviews | $40 - $49,999 Net Worth

Mar 27, 2018 · Macaya Douoguih volunteered to lead an accelerated clinical program for a new investigational Ebola vaccine at the height of the 2014 epidemic in West Africa. She reflects on her experiences—and why her work must continue today. Four years ago, the worst Ebola outbreak in history first emerged.

Dec 6, 2021 · Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Walter Reed Army Institute of Research - Clinical Trials Center, State University of New York (SUNY) - Institute for Global Health and Translational Science, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicin...

Macaya Douoguih M.D. is a Head for Vaccines Clinical Development in the Johnson & Johnson with three videos in the C-SPAN Video Library; the first appearance was a 2020 House Committee. The year...

Congratulations to Macaya Douoguih, M.D., M.P.H. who was recognized as one of 2021’s Fiercest Women in Life Sciences by Fierce Pharma for her tireless work in vaccine research and development....

Macaya Douoguih, M.D., M.P.H., Head of Clinical Development and Medical Affairs, Janssen Vaccines and Prevention, represented Johnson & Johnson before the Oversight and Investigations Subcommittee of the U.S. House Energy & Commerce Committee to present on the status of our SARS-CoV-2 vaccine development program to combat COVID-19.